| NCT ID | NCT06336304 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Laborie Medical Technologies Inc. |
| Condition | Urinary Incontinence |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-06-18 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-06-18 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations
Eligibility Criteria
Inclusion Criteria: * Patients medically indicated for urodynamic study * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements Exclusion Criteria: * Patients or legally authorized representative with cognitive or psychiatric condition that interferes with or precludes direct and accurate communication regarding the study, giving informed consent or ability to complete the patient questionnaire * Patients with confirmed active bladder infections (not including patients with asymptotic bacteria) * Pregnant women * Patients with recent (less than 2 weeks) pelvic floor surgery * Requires use of suprapubic catheter
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06336304 clinical trial?
This trial is open to participants of all sexes, studying Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06336304 currently recruiting?
Yes, NCT06336304 is actively recruiting participants. Contact the research team at rs.nxtpmcf@laborie.com for enrollment information.
Where is the NCT06336304 trial being conducted?
This trial is being conducted at Hanover, United States, Owing Mills, United States, Columbus, United States, Columbus, United States and 1 additional location.
Who is sponsoring the NCT06336304 clinical trial?
NCT06336304 is sponsored by Laborie Medical Technologies Inc.. The trial plans to enroll 180 participants.